Factors responsible for difficult to treat superficial fungal infections: A study from a tertiary healthcare centre in India

Recurrent and clinically unresponsive dermatophytosis is being increasingly observed in India. However, there is little information regarding the extent of the problem and the factors responsible for these difficult to treat superficial fungal infections.

[1]  S. Dogra,et al.  Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT) , 2020, Indian dermatology online journal.

[2]  F. Younus,et al.  Dermatophytosis: an Epidemiological And Clinical Comparative Study in a Tertiary Care Centre , 2020, International Journal of Contemporary Medical Research [IJCMR].

[3]  R. Wani,et al.  Influence of dermatophytosis on quality of life: a cross sectional study from Kashmir Valley in North India , 2020 .

[4]  F. AL-Khikani.  Dermatophytosis a worldwide contiguous fungal infection: Growing challenge and few solutions , 2020 .

[5]  Sonal Singh,et al.  The Current Indian Epidemic of Dermatophytosis: A Study on Causative Agents and Sensitivity Patterns , 2020, Indian journal of dermatology.

[6]  Sanjay Singh,et al.  Risk factors for chronic and chronic-relapsing tinea corporis, tinea cruris and tinea faciei: Results of a case-control study. , 2019, Indian journal of dermatology, venereology and leprology.

[7]  U. Saikia,et al.  A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India , 2018, Indian journal of dermatology, venereology and leprology.

[8]  H. S. Shilpa,et al.  Clinico-Mycological Study of Dermatophytoses at a Tertiary Care Hospital in Belagavi, Karnataka , 2018 .

[9]  M. Vineetha,et al.  Profile of Dermatophytosis in a Tertiary Care Center , 2018, Indian journal of dermatology.

[10]  S. Dogra,et al.  Emerging atypical and unusual presentations of dermatophytosis in India , 2017 .

[11]  S. Verma,et al.  The Great Indian Epidemic of Superficial Dermatophytosis: An Appraisal , 2017, Indian journal of dermatology.

[12]  S. Panda,et al.  The menace of dermatophytosis in India: The evidence that we need , 2017, Indian journal of dermatology, venereology and leprology.

[13]  A. Inamadar,et al.  Clinical failure of antifungal therapy of dermatophytoses: Recurrence, resistance, and remedy , 2017 .

[14]  G. Vani,et al.  Clinico mycological study of dermatophytosis , 2017 .

[15]  Balaji Govindan,et al.  A Clinico-Mycological Study of Chronic Dermatophytosis of More Than Years Duration , 2016 .

[16]  S. Dogra,et al.  The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive? , 2016, Indian dermatology online journal.

[17]  M. García-Romero,et al.  New insights into genes, immunity, and the occurrence of dermatophytosis. , 2015, The Journal of investigative dermatology.

[18]  S. Verma.  Sales, status, prescriptions and regulatory problems with topical steroids in India. , 2014, Indian journal of dermatology, venereology and leprology.

[19]  T. K. Ghosh,et al.  Clinico-mycological profile of Dermatophytosis In a Tertiary Care Hospital in West Bengal An Indian scenario , 2014 .

[20]  V. Bindu,et al.  Clinico-mycological study of dermatophytosis in Calicut. , 2002, Indian journal of dermatology, venereology and leprology.